My Work: establishing a nonprofit pharmaceutical company to develop medicines for neglected diseases.
Check out this video of Victoria Hale's work
By creating the first nonprofit pharmaceutical company in the U.S., Victoria Hale is working to develop safe, effective and affordable drugs to treat neglected diseases that afflict largely rural and poor populations in the developing world.
Victoria grew up in Baltimore, and worked as a pharmacist at Johns Hopkins University Hospital in Baltimore. She earned her PhD in pharmacology at the University of California in San Francisco, reviewed drug applications at the FDA, served as a senior scientist at Genentech and an adviser to the World Health Organization, and co-founded a drug development consulting firm called Axiom Biomedical, Inc. A lifelong admirer of the early women suffragists and of Margaret Sanger, she was one of six women scientists who fought to require pharmaceutical companies to include women and children in clinical trials. This dedicated group was responsible in part for changing the way clinical trials are conducted in the industrialized world. She learned at that moment that a small number of committed people can make a lasting difference on an important issue.By her late 30s, Victoria began rethinking the profession she loved because she felt it had departed from the ideals of healing that originally drew her. During a trip to India, she witnessed the ravages of leishmaniasis and knew she had to do something. She returned determined to start what she had been told was impossible; a non-profit pharmaceutical company specializing in developing drugs for the diseases of the poor. In 2000, Victoria and her husband, Ahvie Herskowitz—a cardiologist by training—founded OneWorld Health to develop safe, affordable and effective new medicines for people living with diseases of poverty in the developing world.